Predominant adverse effects on dulaglutide treatment are gastrointestinal symptoms with nausea (up to 20%) as the largest component. As gastrointestinal symptoms are dose-depended and peak during the first 2 weeks of treatment, the first injection is given at a dose of 0.75 mg. In case of persi...